Were there ever any warnings?

The FDA has issued several Safety Communications as a result of the 921 adverse event reports the organization has received since 2005. Special emphasis has been placed on retrievable filters that have remained in patients for longer than needed. The FDA has recommended that implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters ensure that filters are removed as soon as protection from pulmonary embolism is no longer required.